
XI LUO
Articles
-
Jun 28, 2024 |
nature.com | XI LUO
AbstractMany studies have reported metabolomic analysis of different bio-specimens from Parkinson’s disease (PD) patients. However, inconsistencies in reported metabolite concentration changes make it difficult to draw conclusions as to the role of metabolism in the occurrence or development of Parkinson’s disease. We reviewed the literature on metabolomic analysis of PD patients.
-
Nov 19, 2023 |
nature.com | XI LUO |Haruhiko Koseki |Enrico Glaab
AbstractThe vast majority of Parkinson’s disease cases are idiopathic. Unclear etiology and multifactorial nature complicate the comprehension of disease pathogenesis. Identification of early transcriptomic and metabolic alterations consistent across different idiopathic Parkinson’s disease (IPD) patients might reveal the potential basis of increased dopaminergic neuron vulnerability and primary disease mechanisms.
-
Sep 21, 2023 |
frontiersin.org | Three Gorges |Shanghai Jiao Tong |XI LUO
1. Introduction Accumulating evidence showed that cigarette smoking is associated with respiratory and vascular diseases and even increases the risk of cancer, especially lung cancer (Doll and Hill, 1956). There is a higher mortality due to lung cancer in smokers than in non-smokers and in heavy smokers than in light smokers (Doll and Hill, 1956). It has been affirmed around the world that smoking cessation could significantly improve quality of life (Goldenberg et al., 2014).
-
Feb 12, 2023 |
mdpi.com | Ruifen Zhang |Jun Yan |Hepeng Jia |XI LUO
5. Theoretical Contribution and Practical ImplicationsThe main theoretical contribution of this paper is that it reveals an alternative landscape regarding the determinants of people’s willingness to vaccinate. This study expanded the existing body of literature that explores the politicization of the Chinese public’s attitude towards and intention for COVID-19 vaccination [13,16,35,39].
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →